Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
12.00
+0.18 (1.48%)
Aug 6, 2026, 5:52 AM EDT - Market open
Vicore Pharma Holding AB Market Cap
Vicore Pharma Holding AB has a market cap or net worth of $331.75 million as of August 6, 2026. Its market cap has increased by 44.27% in one year.
Market Cap
331.75M
Enterprise Value
220.05M
1-Year Change
44.27%
Ranking
Category
Stock Price
$12.00
ChartMarket Cap Chart
Since December 10, 2015, Vicore Pharma Holding AB's market cap has increased from $10.33M to $331.75M, an increase of 3,111.32%. That is a compound annual growth rate of 38.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 331.75M | -4.15% |
| Dec 30, 2025 | 346.13M | 92.86% |
| Dec 30, 2024 | 179.47M | 14.25% |
| Dec 29, 2023 | 157.08M | 11.76% |
| Dec 30, 2022 | 140.55M | 27.27% |
| Dec 30, 2021 | 110.43M | -52.45% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Compass Therapeutics | 339.47M |
| Palisade Bio | 336.74M |
| Fennec Pharmaceuticals | 333.13M |
| Zentalis Pharmaceuticals | 331.02M |
| Lexeo Therapeutics | 329.79M |
| Clinuvel Pharmaceuticals | 320.07M |
| Lyell Immunopharma | 315.37M |
| Vanda Pharmaceuticals | 314.51M |